[ad_1]
ID 203586944 © Oleksandr Lutsenko | Dreamstime.com
The case of a 32-year-old doctor, who is in treatment after receiving the Pfizer-BioNTech vaccine against COVID-19, is being studied by the Mexican health authorities.
The doctor, whose name has not been released, was admitted to the Intensive Care Unit of a public hospital in the state of Nuevo León, in northern Mexico, after presenting difficulty breathing, seizures and a skin rash.
“The initial diagnosis is encephalomyelitis,” the health ministry said Friday night, adding that the doctor had a history of allergic reactions and that there was no evidence from clinical trials that someone had developed inflammation in the brain after receiving the vaccine.
Pfizer and BioNTech have yet to comment on the incident.
More than 126,500 people have died from the Covid-19 disease in Mexico. The country began distributing the first dose of the new coronavirus vaccine to healthcare workers on December 24.
► In Finland now, the Medicines Agency has received the first report of a side effect in the Pfizer / BioNTech vaccine, one week after the launch of the mass vaccination campaign in Europe, the Finnish network YLE reported today.
EU member states started the vaccination program in the bloc on December 27, a day after receiving the first supplies of the Pfizer / BioNTech vaccine, following approval by the European Commission.
“When there are at least five such incidents, we will post information on our website about the type of reaction that occurred,” Medical Director Maya Kaukonen told the network, adding that no further details could be given due to personal data. .
At the same time, he noted that reports of allergic reactions or other side effects are likely to increase.
So far, vaccines against the new coronavirus have been administered to healthcare workers in the five largest areas of the country in terms of hospital facilities: Helsinki, Turku, Tampere, Kuopio and Oulu, according to the network report.
